ISB News

Tuberculosis: ‘The Forgotten Plague’

PBS: American Experience Film
“The Forgotten Plague”

BY ISBUSA

The measles outbreak and subsequent fueling of the anti-vaccination debate have monopolized headlines recently. But there’s a “plague” that causes an estimated 1.3 million deaths per year that researchers, including those at Institute for Systems Biology, are dedicated to tackling: tuberculosis. On Tuesday, Feb. 10, PBS will feature an “American Experience” film “The Forgotten Plague” on the history of tuberculosis and how difficult it has been to eradicate this disease. Check local listings for times.

LEARN MORE ABOUT ISB’S TUBERCULOSIS RESEARCH:

Pushing the Molecular Switches of Tuberculosis Into Overdrive to Map Interactions

Uncovering the Genetic Adaptability of Tuberculosis

ISB Researchers Identify New Protein Modification Critical to Growth of Tuberculosis Pathogen

ISB Researchers Collaborate on $16.6 Million Tuberculosis Grant

TB IN KING COUNTY, WA:

KCTS 9 shared a report on TB stats for King County to dovetail with the Frontline episode “TB Silent Killer.” Learn more..


 

Related Articles

  • Spotlight on Amy Zamora, ISB Systems Research Scholar

    Amy Zamora joined ISB in August as a Systems Research Scholar. The Systems Research Scholars Program provides recent college undergraduates a springboard to become the next generation’s pioneers of interdisciplinary scientific research. In this Q&A, Zamora describes her experiences at ISB, research interests, future aspirations, and much more.

    Read More
  • ISB’s Dr. Eliza Peterson Earns TB Junior Investigator Award

    Dr. Eliza Peterson, a senior research scientist who studies tuberculosis (TB) in the Institute for Systems Biology’s Baliga Lab, has been recognized by the University of Washington’s Tuberculosis Research and Training Center with a TB Junior Investigator Award.

    Read More
  • NIH Research Matters Features ISB’s MTB Paper

    NIH Research Matters published an article on our tuberculosis paper. “The incredibly large number of possible drug combinations taken together with the difficulty of growing Mtb in the laboratory make discovery of effective combination therapy extremely challenging,” Dr. Nitin Baliga says. “We hope that our systems-based strategy will accelerate TB drug discovery by helping researchers prioritize combinations that are more likely to be effective.” READ THE ARTICLE

    Read More
Show More Articles